FDA To Companion Dx Developers: Pre-Trial Assay Validation Is Key
This article was originally published in The Pink Sheet Daily
Executive Summary
The assay is used to select the target population enrolled in the trial, and the safety and efficacy of the drug are determined based on this population, CDRH's Roscoe emphasized to an assemblage of biomedical researchers, entrepreneurs and other stakeholders.